FUSION BARS, DID YOU KNOW?

WISCONSIN

First In-Kind Psychedelic Trial to Treat OPIOD and Methamphetamine Use Disorders.

Fusion bars, Psilocybin has shown encouraging results for patients with depression and with tobacco and alcohol misuse. Now, a UW-Madison research team is investigating the use of psilocybin to aid in decreasing opioid and methamphetamine misuse.

Official Fusion Bars “we’re excited to see what it can do along those same lines for patients struggling with substance abuse, many of whom have overlapping mental health conditions. ” Official fusion bars says Huston, a co-investigator on both studies.

BY Katie Gerhards,

University of Wisconsin-Madison.